202 related articles for article (PubMed ID: 24878319)
1. Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA.
Cain-Nielsen AH; Moriarty JP; Stewart EA; Borah BJ
J Comp Eff Res; 2014 Sep; 3(5):503-14. PubMed ID: 24878319
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
Babashov V; Palimaka S; Blackhouse G; O'Reilly D
Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids.
O'Sullivan AK; Thompson D; Chu P; Lee DW; Stewart EA; Weinstein MC
Int J Technol Assess Health Care; 2009 Jan; 25(1):14-25. PubMed ID: 19126247
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids.
Zowall H; Cairns JA; Brewer C; Lamping DL; Gedroyc WM; Regan L
BJOG; 2008 Apr; 115(5):653-62. PubMed ID: 18333948
[TBL] [Abstract][Full Text] [Related]
5. MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis.
Kong CY; Meng L; Omer ZB; Swan JS; Srouji S; Gazelle GS; Fennessy FM
AJR Am J Roentgenol; 2014 Aug; 203(2):361-71. PubMed ID: 25055272
[TBL] [Abstract][Full Text] [Related]
6. Uterine artery embolisation or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial.
Rana D; Wu O; Cheed V; Middleton LJ; Moss J; Lumsden MA; McKinnon W; Daniels J; Sirkeci F; Manyonda I; Belli AM; McPherson K;
BJOG; 2021 Oct; 128(11):1793-1802. PubMed ID: 34053154
[TBL] [Abstract][Full Text] [Related]
7. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
Daniels J; Middleton LJ; Cheed V; McKinnon W; Rana D; Sirkeci F; Manyonda I; Belli AM; Lumsden MA; Moss J; Wu O; McPherson K
Health Technol Assess; 2022 Apr; 26(22):1-74. PubMed ID: 35435818
[TBL] [Abstract][Full Text] [Related]
8. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
You JH; Sahota DS; Yuen PM
Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
[TBL] [Abstract][Full Text] [Related]
9. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
10. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract][Full Text] [Related]
11. Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study.
Wu O; Briggs A; Dutton S; Hirst A; Maresh M; Nicholson A; McPherson K
BJOG; 2007 Nov; 114(11):1352-62. PubMed ID: 17949377
[TBL] [Abstract][Full Text] [Related]
12. The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis.
Xu F; Deng L; Zhang L; Hu H; Shi Q
Int J Hyperthermia; 2021 Sep; 38(2):24-29. PubMed ID: 34420449
[TBL] [Abstract][Full Text] [Related]
13. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
14. Uterine and Fibroid Imaging Analysis from the FIRSTT Study.
Laughlin-Tommaso SK; Gorny KR; Hesley GK; Vaughan LE; Woodrum DA; Lemens MA; Stewart EA
J Womens Health (Larchmt); 2022 Apr; 31(4):546-554. PubMed ID: 34242085
[No Abstract] [Full Text] [Related]
15. Artifact from myomectomy/C-Section on MRI images - what does this mean for MR-guided focused ultrasound candidacy for uterine fibroids?
Sinha V; Mehta S; Kalantzis G; Steinberg F; LeBlang SD
Int J Hyperthermia; 2019; 36(1):1079-1083. PubMed ID: 31709842
[No Abstract] [Full Text] [Related]
16. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
17. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates.
Ikink ME; Nijenhuis RJ; Verkooijen HM; Voogt MJ; Reuwer PJ; Smeets AJ; Lohle PN; van den Bosch MA
Eur Radiol; 2014 Oct; 24(10):2649-57. PubMed ID: 25117743
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids.
Thao V; Moriarty JP; Stewart EA; Borah BJ
J Minim Invasive Gynecol; 2023 Oct; 30(10):813-819. PubMed ID: 37286130
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors.
Mohr-Sasson A; Machtinger R; Mashiach R; Nir O; Inbar Y; Maliyanker N; Goldenberg M; Rabinovici J
Am J Obstet Gynecol; 2018 Oct; 219(4):375.e1-375.e7. PubMed ID: 30217580
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids.
Beinfeld MT; Bosch JL; Isaacson KB; Gazelle GS
Radiology; 2004 Jan; 230(1):207-13. PubMed ID: 14695395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
